Biochemical markers in osteoporosis

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 57, Issue 227, 1997, Pages 6-11

  Kanis, John A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; DEOXYPYRROLIDINONE; HYDROXYPROLINE; OSTEOCALCIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ANALYTICAL ERROR; BONE DENSITY; CONFERENCE PAPER; FRACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MENOPAUSE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CROSS LINKING; RISK ASSESSMENT; URINALYSIS; AGED; FEMALE; METABOLISM; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 0030899224     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709168303     Document Type: Conference Paper

References (23)

1. van Hemert AM, Birkenhager JC, de Jong FH, Vandenbroucke JP, Valkenburg HA. Sex hormone binding globulin in postmenopausal women: A predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol 1989; 31: 499-509.
2. Ralston SH. Scand J Clin Lab Invest 1997;57 (Suppl 227):114-121.
3. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1991; 90: 107-110.
4. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. 1994, WHO, Geneve.
5. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141.
6. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover is a major determinant of osteoporosis in elderly women. J Bone Miner Res 1996; 3: 337-349.
7. Kanis JA, McCloskey EV, Eyres KS, O'Doherty DV, Aaron JE. Screening techniques in the evaluation of osteoporosis. In: HRT and osteoporosis. Eds. Drife JO, Studd JWW; Springer Verlag: London. Chapter 12, 1990; pp 135-147.
8. Christiansen C, Riis BJ, Nilas L, Rodbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet 1985; 2: 800-801.
9. Morris HA, Wishart JM, Horowitz M, Need AG, Nordin BEC. The reproducibility of bone-related biochemical variables in postmenopausal women. Ann Clin Biochem 1990; 27: 562-568.
10. Vasikaran SD, McCloskey EV, Khan S, Kanis JA. Intra-individual variation in fasting urinary calcium- and hydroxyproline-creatinine ratios measured in metabolic bone clinic patients as both outpatients and inpatients. Ann Clin Biochem 1994; 31: 1-5.
11. Riis BJ. The role of bone loss. Am J Med 1995; 98 (suppl 2A): 29-32.
12. Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105-1108.
13. Hansen M, Overgaard K, Riis B. Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. Br Med J 1991; 303: 961-964.
14. Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BOP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988; 18: 191-195.
15. Christiansen C. What should be done at the time of menopause? Am J Med 1995; 98 (suppl 2A): 56-59.
16. Uebelhart D, Schlemmer A, Johansen JS. Gineyts, Christiansen C, Delmas PD. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 1991; 72: 367-373.
17. Kanis JA, Adami S. Bone loss in the elderly. Osteoporosis Int 1994; 4 (suppl I): 59-65.
18. Garnero P, Hansherr E. Chapuy MC. Marcelli C. Grandjean H, Muller C, Cormier C. Breart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS study. J Bone Miner Res 1997; in press.
19. Kanis JA, McCloskey EV. Evaluation of the risk of hip fracture. Bone 1996: 18: 127s-132s.
20. Wishart JM, Need AG. Horowitz M, Morris HA. Nordin BEC. Effect of age on bone density and bone turnover in men. Clin Endocrinol 1995; 42: 141-146.
21. Chesnut CH, McClung MR. Ensrud KE, Bell NH, Genant HK. Harris ST. Singer FR, Stock JL, Yood RL, Delmas PD. Kher U, Pryor-Tillotson S, Santora AC. Alendronate treatment of the postmenopausal osteoporotic women: effect of multiple dosages on bone mass and bone remodeling. Am J Med 1995; 99: 142-152.
22. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79: 1693-1700.
23. Munk Nielsen N, von der Recke P, Hansen MA, Overgaard K, Christiansen C. Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers. Calcif Tissue Int 1994; 55: 8-11.